Format

Send to

Choose Destination
BMC Infect Dis. 2016 Oct 13;16(1):568.

Outcome of patients with streptococcal prosthetic joint infections with special reference to rifampicin combinations.

Author information

1
Infectious Diseases Department, University Hospital of Rouen, Rouen, France.
2
Laboratory of Microbiology, University Hospital of Lille, Lille, France.
3
Infectious Diseases Department, Gustave Dron Hospital of Tourcoing, 135 rue du Président Coty, 59200, Tourcoing, France.
4
Unit of Infectious Diseases Hospital 12 de Octubre of Madrid, Madrid, Spain.
5
Infectious Diseases Department, University Hospital of Amiens, Amiens, France.
6
Laboratory of Microbiology, University Hospital of Rouen, Rouen, France.
7
Laboratory of Microbiology, Gustave Dron Hospital of Tourcoing, Tourcoing, France.
8
Orthopaedic Surgery Unit, University Hospital of Amiens, Amiens, France.
9
Orthopaedic Surgery Unit, University Hospital of Rouen, Rouen, France.
10
Orthopaedic Surgery Unit, Gustave Dron Hospital of Tourcoing, Tourcoing, France.
11
Laboratory of Microbiology, University Hospital of Caen, Caen, France.
12
Orthopaedic Surgery Unit, University Hospital of Caen, Caen, France.
13
Orthopaedic Surgery Unit, University Hospital of Lille, Lille, France.
14
Infectious Diseases Department, Gustave Dron Hospital of Tourcoing, 135 rue du Président Coty, 59200, Tourcoing, France. esenneville@ch-tourcoing.fr.
15
French Reference Center for Osteo-Articular Infections (CRIOAC Lille-Tourcoing), Faculty Hospital of Lille, Lille, France. esenneville@ch-tourcoing.fr.

Abstract

BACKGROUND:

Outcome of patients with streptococcal prosthetic joint infections (PJIs) is not well known.

METHODS:

We performed a retrospective multicenter cohort study that involved patients with total hip/knee prosthetic joint (THP/TKP) infections due to Streptococcus spp. from 2001 through 2009.

RESULTS:

Ninety-five streptococcal PJI episodes (50 THP and 45 TKP) in 87 patients of mean age 69.1 ± 13.7 years met the inclusion criteria. In all, 55 out of 95 cases (57.9 %) were treated with debridement and retention of the infected implants with antibiotic therapy (DAIR). Rifampicin-combinations, including with levofloxacin, were used in 52 (54.7 %) and 28 (29.5 %) cases, respectively. After a mean follow-up period of 895 days (IQR: 395-1649), the remission rate was 70.5 % (67/95). Patients with PJIs due to S. agalactiae failed in the same proportion as in the other patients (10/37 (27.1 %) versus 19/58 (32.7 %); p = .55). In the univariate analysis, antibiotic monotherapy, DAIR, antibiotic treatments other than rifampicin-combinations, and TKP were all associated with a worse outcome. The only independent variable significantly associated with the patients' outcomes was the location of the prosthesis (i.e., hip versus knee) (OR = 0.19; 95 % CI 0.04-0.93; p value 0.04).

CONCLUSIONS:

The prognosis of streptococcal PJIs may not be as good as previously reported, especially for patients with an infected total knee arthroplasty. Rifampicin combinations, especially with levofloxacin, appear to be suitable antibiotic regimens for these patients.

KEYWORDS:

Outcome; Prosthetic joint infection; Rifampicin; Risk factors; Streptococcus spp

PMID:
27737642
PMCID:
PMC5064929
DOI:
10.1186/s12879-016-1889-0
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center